BOARD OF DIRECTORS
The Cancer Research & Treatment Fund (CR&T) is led by a Board of Directors that is supported by our Medical Advisory Board. Together, they represent a broad cross-section of specialties and disciplines, working together to rapidly deploy funding to the frontlines of research and ensuring CR&T maintains its reputation as a leading voice in cancer research.
Thomas M. Silver, President
Principal, Silver Dollar Ventures, LLC.
Richard T. Silver, MD, Vice President, Medical Director
New York-Presbyterian/Weill Cornell Medicine
Joseph N. Aimi
President, Kenneth Bieber, Inc.
David T. Boule, Treasurer
Retired Partner, Ernst & Young
Maria Brisbane, CFA
Managing Director, Merrill Lynch
President, Mr. Christmas, Inc.
Michael C. Kempner
Managing General Partner, KS Capital Partners, LP
Amanda Johns Perez
Jeffrey Puglisi, MD
Glenville Medical Concierge Care
Richard J. Rose
Sr. Managing Director, Shufro, Rose & Co., LLC (Retired)
Todd J. Shaw
Senior Vice President, Morgan Stanley
Bharat Shah, PhD
Past President, Noble Investment Group (Retired)
Strategy/Business Development Manager, Pure Storage
Portfolio Manager, Empery Asset Management, LP
Nelson A. Boxer
Partner, Petrillo Klein & Boxer LLP
Chad Feay, MA, CHES®
Director of Administration and Development